RECRUITING

Patient Controlled Administration of Liquid Acetaminophen

Description

This is a proof of concept pilot study investigating the feasibility and acceptability of patient controlled oral medication administration, using the commonly used and low risk medication in the hospital, oral acetaminophen.

Study Overview

Study Details

Study overview

This is a proof of concept pilot study investigating the feasibility and acceptability of patient controlled oral medication administration, using the commonly used and low risk medication in the hospital, oral acetaminophen.

Patient Controlled Self-Administration of Oral Liquid Medication: Acetaminophen Trial

Patient Controlled Administration of Liquid Acetaminophen

Condition
Pain
Intervention / Treatment

-

Contacts and Locations

New Haven

Yale New Haven Hospital at St. Raphael's Campus, New Haven, Connecticut, United States, 06520

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Adult patients older than 18 years old admitted to SRC for total shoulder and reverse total shoulder arthroplasty
  • * The nurse who will administer acetaminophen to a study patient.
  • * Pregnant patient
  • * Patients that cannot swallow pills or cannot take liquid (for example due to risk of aspiration)
  • * Emergency surgery
  • * Chronic pain
  • * On home opioids, any other pain modulating medications including benzodiazepine, Neurontin, ketamine.
  • * Past medical or social history of substance abuse disorder, including ethanol misuse disorder, marijuana misuse disorder
  • * History of any psychiatric disorders including anxiety, depression, any cognitive dysfunction
  • * Any patients who cannot provide informed consents on their own (those who would need Legally Authorized Representatives (LARs) or surrogates)
  • * Liver dysfunction limiting amount of safe oral acetaminophen
  • * baseline hyperbilirubinemia (ex: chronic liver disease, Gilbert's)
  • * patients unable to take PO
  • * Patients with neurologic, neuromuscular, or movement disorders unable to drink from a cup.
  • * any nurse who is not involved in the direct care of a study patient, or who is not comfortable with setting up the PCA pump.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Yale University,

Jinlei Li, MD, PhD, PRINCIPAL_INVESTIGATOR, Yale University

Study Record Dates

2025-08